logo
Plus   Neg
Share
Email

UnitedHealth Maintains FY20 Earnings Outlook - Quick Facts

UnitedHealth Group (UNH) maintained its full year earnings per share outlook for 2020 of net earnings of $15.45 to $15.75 per share and adjusted net earnings of $16.25 to $16.55 per share.

Second quarter adjusted earnings per share was $7.12 compared to $3.60, previous year. On average, 24 analysts polled by Thomson Reuters expected the company to report profit per share of $5.18, for the quarter. Analysts' estimates typically exclude special items.

Second quarter revenues increased to $62.14 billion from $60.60 billion prior year, reflecting growth at Optum and the UnitedHealthcare public-sector and senior businesses, partially offset by economic-related impacts at UnitedHealthcare commercial and global. Analysts expected revenue of $63.43 billion for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amid the growing climate crisis, Walmart said it is raising its ambition to zero emissions by 2040, without the use of carbon offsets, across its global operations. The retail giant, along with the Walmart Foundation, also committed to help protect, manage or restore at least 50 million acres of land and one million square miles of ocean by 2030. The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020.
Follow RTT